Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 654-660

  Sauter, Edward R ^a,b,c   Herlyn, Meenhard ^b   Liu, Shao Chen ^a   Litwin, Samuel ^a   Ridge, John A ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b WISTAR INSTITUTE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1;

ARTICLE; CANCER GROWTH; CANCER REGRESSION; CARCINOGENESIS; CONTROLLED STUDY; GENE THERAPY; HUMAN; HUMAN CELL; MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE; CELL LINE, TRANSFORMED; CYCLIN D1; DNA, ANTISENSE; GENE THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; KERATINOCYTES; MICE; MICE, SCID; SKIN NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0033976137     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Jin, Y. S., Higashi, K., Mandahl, N., Heim, S., Wennerberg, J., Bjorklund, A., Dictor, M., and Mitelman, F. Frequent rearrangement of chromosomal bands 1p22 and 11q13 in squamous cell carcinomas of the head and neck. Genes Chromosomes Cancer, 2: 198-204, 1990.
2. Leonard, J. H., Kearsley, J. H., Chenevix-Trench, G., and Hayward, N. K. Analysis of gene amplification in head-and-neck squamous-cell carcinoma. Int. J. Cancer, 48: 511-515, 1991.
3. 1 regulation in human head and neck cancer. Cancer Res., 55: 949-956, 1995.
4. Adelaide, J., Monges, G., Derderian, C., Seitz, J. F., and Birnbaum, D. Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br. J. Cancer, 71: 64-68, 1995.
5. Arnold, A., Kim, H. G., Gaz, R. D., Eddy, R. L., Fukushima, Y., Byers, M. G., Shows, T. B., and Kronenberg, H. M. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J. Clin. Invest., 83: 2034-2040, 1989.
6. Motokura, T., and Arnold, A. PRAD1/cyclin D1 proto-oncogene: genomic organization, 5′ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Cancer, 7: 89-95, 1993.
7. 1 phase in rodent fibroblasts. Genes Dev., 7: 1559-1571, 1993.
8. 1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8: 3447-3457, 1993.
9. Hinds, P. W., Dowdy, S. F., Eaton, E. N., Arnold, A., and Weinberg, R. A. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA, 91: 709-713, 1994.
10. Lovec, H., Sewing, A., Lucibello, F. C., Muller, R., and Moroy, T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene, 9: 323-326, 1994.
11. Palmero, I., and Peters, G. Perturbation of cell cycle regulators in human cancer. Cancer Surv., 27: 351-367, 1996.
12. Andl, T., Kahn, T., Pfuhl, A., Nicola, T., Erber, R., Conradt, C., Klein, W., Helbig, M., Dietz, A., Weidauer, H., and Bosch, F. X. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res., 58: 5-13, 1998.
13. Loughran, O., Malliri, A., Owens, D., Gallimore, P. H., Stanley, M. A., Ozanne, B., Frame, M. C., and Parkinson, E. K. Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene, 13: 561-568, 1996.
14. Akiyama, T., Yoshida, T., Tsujita, T., Shimizu, M., Mizukami, T., Okabe, M., and Akinaga, S. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. Cancer Res., 57: 1495-1501, 1997.
15. Waber, P., Dlugosz, S., Cheng, Q. C., Truelson, J., and Nisen, P. D. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a. Oncogene, 15: 1699-1704, 1997.
16. Gonzalez, M. V., Pello, M. F., Lopez-Larrea, C.. Suarez, C., Menendez, M. J., and Coto, E. Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma. J. Clin. Pathol., 50: 509-512, 1997.
17. Busatto, G., Shiao, Y. H., Parenti, A. R., Baffa, R., Ruol, A., Plebani, M., and Rugge, M. p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma. Mol. Pathol., 51: 80-84, 1998.
18. El-Naggar, A. K., Lai, S., Clayman, G., Lee, J. K., Luna, M. A., Goepfert, H., and Batsakis, J. G. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am. J. Pathol., 151: 1767-1774, 1997.
19. Soufir, N., Avril, M. F., Chompret, A., Demenais, F., Bombled, J., Spatz, A., Stoppa-Lyonnet, D., Benard, J., and Bressac-de Paillerets, B. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum. Mol. Genet. 1998 May;7(5):941]. Hum Mol Genet., 7: 209-216, 1998.
20. Liu, S. C., Sauter, E. R., Clapper, M. L., Feldman, R. S., Levin, L., Chen, S. Y., Yen, T. J., Ross, E., Engstrom, P. F., and Klein-Szanto, A. J. Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity. Cancer Epidemiol. Biomark. Prev., 7: 597-603, 1998.
21. Sauter, E. R., Nesbit, M., Litwin, S., Klein-Szanto, A. J. P., Cheffetz, S., and Herlyn, M. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res., 59: 4876-4881, 1999.
22. Dietrich, C., Wallenfang, K., Oesch, F., and Wieser, R. Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts. Oncogene, 15: 2743-2747, 1997.
23. Southgate, J., Williams, H. K., Trejdosiewicz, L. K., and Hodges, G. M. Primary culture of human oral epithelial cells: growth requirements and expression of differentiated characteristics. Lab. Invest., 56: 211-223, 1987.
24. Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol., 36: 59-74, 1977.
25. Satyamoorthy, K., Nesbit, M., Hsu, M.-Y., and Herlyn, M. Utility of Adenoviruses as Gene Expression Modules in Melanoma, p. 77. Amsterdam: IOS Press, 1996.
26. Ranheim, T. S., Shisler, J., Horton, T. M., Wold, L. J., Gooding, L. R., and Wold, W. S. Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. J. Virol., 67: 2159-2167, 1993.
27. Hirt, B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol., 26: 365-369, 1967.
28. Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Paakko, P. K., Gilardi, P., Stratford-Perricaudet, L. D., Perricaudet, M., and et al. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo [see comments]. Science (Washington DC), 252: 431-434, 1991.
29. Graham, F. L., and Eb, A. J. v. d. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52; 456-467, 1973.
30. Kotelnikov, V. M., Coon, J. S., Taylor, S., Hutchinson, J., Panje, W., Caldarelli, D. D., LaFollette, S., and Preisler, H. D. In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region. Cell Prolif., 28: 497-509, 1995.
31. Maidhof, R., and Hornstein, O. P. Autoradiographic study on some proliferative properties of human buccal mucosa. Arch. Dermatol. Res., 265: 165-172, 1979.
32. Kurzrock, R., Ku, S., and Talpaz, M. Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. Cancer (Phila.), 75: 584-590, 1995.
33. Naitoh, H., Shibata, J., Kawaguchi, A., Kodama, M., and Hattori, T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am. J. Pathol., 146: 1161-1169, 1995.
34. Liu, T. J., Zhang, W. W., Taylor, D. L., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
35. Hamada, K., Alemany, R., Zhang, W. W., Hittelman, W. N., Lotan, R., Roth, J. A., and Mitchell, M. F. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. Cancer Res., 56: 3047-3054, 1996.
36. Cagnoli, M., Barbieri, F., Bruzzo, C., and Alama, A. Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines. Gynecol. Oncol., 70: 372-377, 1998.
37. Hung, W. C., Huang, J. S., and Chuang, L. Y. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression. Biochem. Biophys. Res. Commun., 220: 719-723, 1996.
38. Driscoll, B., Wu, L., Buckley, S., Hall, F. L., Anderson, K. D., and Warburton, D. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. Am. J. Physiol., 273: L941-L949, 1997.
39. Wang, M. B., Billings, K. R., Venkatesan, N., Hall, F. L., and Srivatsan, E. S. Inhibition of cell proliferation in head and neck squamous cell carcinoma cell lines with antisense cyclin D1. Otolaryngol. Head Neck Surg., 119: 593-599, 1998.
40. Kornmann, M., Arber, N., and Korc, M. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J. Clin. Invest., 101: 344-352, 1998.
41. Zhou, P., Jiang, W., Zhang, Y. J., Kahn, S. M., Schieren, I., Santella, R. M., and Weinstein, I. B. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene, 11: 571-580, 1995.
42. Arber, N., Doki, Y., Han, E. K., Sgambato, A., Zhou, P., Kim, N. H., Delohery, T., Klein, M. G., Holt, P. R., and Weinstein, I. B. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res., 57: 1569-1574, 1997.